SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-23-006428
Filing Date
2023-07-28
Accepted
2023-07-28 14:37:01
Documents
17

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 3217183
2 GRAPHIC g609070g00a15.jpg GRAPHIC 41790
3 GRAPHIC g609070g00m61.jpg GRAPHIC 101488
4 GRAPHIC g609070g00m62.jpg GRAPHIC 90835
5 GRAPHIC g609070g00y99.jpg GRAPHIC 81709
6 GRAPHIC g609070g01b19.jpg GRAPHIC 145097
7 GRAPHIC g609070g03a03.jpg GRAPHIC 67436
8 GRAPHIC g609070g27m05.jpg GRAPHIC 94459
9 GRAPHIC g609070g27m26.jpg GRAPHIC 87059
10 GRAPHIC g609070g29f00.jpg GRAPHIC 121855
11 GRAPHIC g609070g39i77.jpg GRAPHIC 56303
12 GRAPHIC g609070g56a56.jpg GRAPHIC 71451
13 GRAPHIC g609070g59g59.jpg GRAPHIC 61699
14 GRAPHIC g609070g60a60.jpg GRAPHIC 53930
15 GRAPHIC g609070g64a10.jpg GRAPHIC 127536
16 GRAPHIC g609070g64b20.jpg GRAPHIC 104257
17 GRAPHIC g609070g67a67.jpg GRAPHIC 109943
  Complete submission text file 0000950123-23-006428.txt   5172228
Mailing Address 7 BD HAUSSMANN PARIS I0 75009
Business Address 7 BD HAUSSMANN PARIS I0 75009 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06511 | Film No.: 231122346
SIC: 2834 Pharmaceutical Preparations